BANK VONTOBEL/CALL/DANAHER/250/0.1/20.12.24 Share Price

Warrant

DE000VD3R1Z7

Market Closed - Boerse Frankfurt Warrants 11:26:09 05/07/2024 pm IST
1.33 EUR -4.32% Intraday chart for BANK VONTOBEL/CALL/DANAHER/250/0.1/20.12.24
Current month-33.83%
1 month-58.04%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 1.33 -4.32%
04/24/04 1.39 -0.71%
03/24/03 1.4 -2.10%
02/24/02 1.43 -12.80%
01/24/01 1.64 -18.41%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 11:26 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DANAHER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3R1Z
ISINDE000VD3R1Z7
Date issued 09/04/2024
Strike 250 $
Maturity 20/12/2024 (167 Days)
Parity 10 : 1
Emission price 2.11
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 3.23
Lowest since issue 1.31
Delta0.49x
Omega 8.020
Premium10.59x
Gearing16.41x
Moneyness 0.9570
Difference Strike 10.75 $
Difference Strike %+4.30%
Spread 0.01
Spread %0.74%
Theoretical value 1.345
Implied Volatility 25.78 %
Total Loss Probability 57.88 %
Intrinsic value 0.000000
Present value 1.345
Break even 264.58 €
Theta-0.04x
Vega0.06x
Rho0.04x

Company Profile

Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Sector
-
More about the company

Ratings for Danaher Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Danaher Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
239.2 USD
Average target price
274.8 USD
Spread / Average Target
+14.86%
Consensus